Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed

被引:95
作者
Liu, Xiaoxuan [1 ,2 ,3 ,4 ]
Rivera, Samantha Cruz [5 ]
Faes, Livia [4 ,6 ]
Di Ruffano, Lavinia Ferrante [7 ]
Yau, Christopher [8 ,9 ]
Keane, Pearse A. [10 ]
Ashrafian, Hutan [11 ]
Darzi, Ara [11 ]
Vollmer, Sebastian J. [9 ,12 ]
Deeks, Jonathan [7 ]
Bachmann, Lucas [13 ]
Holmes, Christopher [3 ,9 ]
Chan, An Wen [14 ]
Moher, David [15 ,16 ]
Calvert, Melanie J. [5 ]
Denniston, Alastair K. [1 ,2 ,3 ,5 ,10 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[3] Hlth Data Res UK, London, England
[4] Moorfields Eye Hosp NHS Fdn Trust, London, England
[5] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England
[6] Cantonal Hosp Lucerne, Dept Ophthalmol, Luzern, Switzerland
[7] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England
[8] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England
[9] Alan Turing Inst, London, England
[10] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res BRC Ophthalmol, London, England
[11] Imperial Coll London, Patient Safety Translat Res Ctr, London, England
[12] Univ Warwick, Coventry, W Midlands, England
[13] Medignition, Zurich, Switzerland
[14] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON, Canada
[15] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada
[16] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
基金
英国惠康基金;
关键词
D O I
10.1038/s41591-019-0603-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As artificial intelligence moves into the realm of clinical trials, consideration is needed on whether the current CONSORT and SPIRIT reporting statements are sufficient to ensure transparency.
引用
收藏
页码:1467 / 1468
页数:2
相关论文
共 6 条
  • [1] Avoidable waste in the production and reporting of research evidence
    Chalmers, Iain
    Glasziou, Paul
    [J]. LANCET, 2009, 374 (9683) : 86 - 89
  • [2] SPIRIT 2013: new guidance for content of clinical trial protocols
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Altman, Douglas G.
    Dickersin, Kay
    Moher, David
    [J]. LANCET, 2013, 381 (9861) : 91 - 92
  • [3] Reporting of artificial intelligence prediction models
    Collins, Gary S.
    Moons, Karel G. M.
    [J]. LANCET, 2019, 393 (10181) : 1577 - 1579
  • [4] EQUATOR Network, REP GUID DEV
  • [5] Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1136/bmj.c869, 10.1186/1741-7015-8-18, 10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1136/bmj.c332, 10.1016/j.ijsu.2011.09.004]
  • [6] US Food and Drug Administration, ART INT MACH LEARN S